Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways

European Journal of Immunology

Volumn 31, Issue 9, 2001, Pages 2529-2538

  Netea, Mihai G ^a   Kullberg, Bart Jan ^a   Joosten, Leo A B ^a   Sprong, Tom ^a   Verschueren, Ineke ^a   Boerman, Otto C ^a   Amiot, Franck ^a   Van Den Berg, Wim B ^a   Van Der Meer, Jos W M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

Cytokine; Infectious immunity; Knock out; LPS; Transgenic

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 8; LYMPHOTOXIN; PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; ENZYME DEFICIENCY; ESCHERICHIA COLI; HYPOTHESIS; IMMUNITY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; KNOCKOUT MOUSE; LETHALITY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIBODIES; BACTERIAL PROTEINS; CASPASE 1; CYTOKINES; ENDOTOXEMIA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; INTERFERON TYPE II; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; LYMPHOTOXIN-ALPHA; MICE; MICE, KNOCKOUT; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SIALOGLYCOPROTEINS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034816334     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200109)31:9<2529::AID-IMMU2529>3.0.CO;2-B     Document Type: Article

References (43)

1. Ajunctive therapy for septic shock: A review of experimental approaches
2. Cytokines and the response to infections
3. Passive immunization against cachexin/tumor necrosis factor protects mice from lethal effect of endotoxin
4. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
5. Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis
6. Cytokine production after intravenous or peritoneal Gram-negative bacterial challenge in mice
7. Recombinant soluble tumor necrosis factor proteins protect mice from lipopolysaccharide-induced lethality
8. Detection of tumor necrosis factor-like cytotoxicity in serum from patients with septicaemia, but not from untreated cancer patients
9. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever
10. Tumor necrosis factor and sepsis: Mediator of multiple organ failure or essential part of host defense?
11. Immune and inflammatory responses in TNFalpha-deficient mice: A critical requirement for TNFalpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the humoral immune response
12. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
13. Decreased sensitivity to tumour necrosis factor but normal T cell development in TNF receptor-2-deficient mice
14. Lipopolysaccharide-induced cytokine cascade and lethality in lymphotoxin-alpha/tumor necrosis factor-alpha deficient mice
15. Characterization of tumor necrosis factor-deficient mice
16. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor alpha-deficient mice
17. Bacterial endotoxins: Chemical structure, biological activity and role in septicaemia
18. Altered cytokine export and apoptosis in mice deficient in interleukin-β converting enzyme
19. Endotoxin-induced early gene expression in C3H/HeJ (LPS-d) macrophages
20. Immunostimulation of C3H/HeJ lymphoid cells by R-chemotype lipopolysaccharide preparations
21. Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality
22. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
23. Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: Biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage
24. Selective species specificity of tumor necrosis factor for toxicity in the mouse
25. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans
26. Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis
27. Effect of endotoxin in IL-1β-deficient mice
28. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
29. Interferon-γ: Biology and role in pathogenesis
30. Lipopolisaccharide-sensitivity of interferon-gamma receptor deficient mice
31. Interferon-γ deficient mice are resistant to endotoxic shock
32. Neutralization of interleukin-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia
33. Lipid A, the endotoxic center of bacterial lipopolysacharides: Relation of chemical structure to biological activity
34. Concepts of the chemical structure of lipid A
35. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin
36. Toll-llike receptor-2 mediates lipopolysaccharide-induced cellular signalling
37. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
38. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
39. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4
40. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression
41. Resistance to fever induction and impaired acute-phase response in interleukin-1β deficient mice
42. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice
43. Low-density-lipoprotein receptor deficient mice are protected against lethal endotoxinemia and severe Gram-negative infections